Effect of neoadjuvant chemoradiotherapy on prognosis in resectable and borderline resectable pancreatic cancer with venous involvement.

被引：0
|
作者：
Nagai, Minako [1 ]
Sho, Masayuki [1 ]
Akahori, Takahiro [1 ]
Nakagawa, Kenji [1 ]
Nakamura, Kota [1 ]
Takagi, Tadataka [1 ]
Tanaka, Toshihiro [1 ]
Nishiofuku, Hideyuki [1 ]
Kichikawa, Kimihiko [1 ]
Ikeda, Naoya [1 ]
机构：
[1] Nara Med Univ, Kashihara, Nara, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.343
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
343
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] Neoadjuvant Chemoradiotherapy With S-1 in Patients With Borderline Resectable Pancreatic Cancer with Involvement of the Major Artery
    Suenaga, M.
    Fujii, T.
    Yamada, S.
    Okumura, N.
    Kobayashi, D.
    Tanaka, C.
    Nakayama, G.
    Sugimoto, H.
    Koike, M.
    Nomoto, S.
    Fujiwara, M.
    Takeda, S.
    Nakao, A.
    Kodera, Y.
    PANCREAS, 2012, 41 (08) : 1405 - 1405
  • [24] The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer
    Kim, H. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A138 - A138
  • [25] Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer
    Hattori, Masashi
    Fujii, Tsutomu
    Suenaga, Masaya
    Yamada, Suguru
    Kanda, Mitsuro
    Iwata, Naoki
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [26] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [27] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [28] Venous Thromboembolism Prophylaxis During Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer-Is it indicated?
    Krepline, Ashley N.
    Christians, Kathleen K.
    George, Ben
    Ritch, Paul S.
    Erickson, Beth A.
    Tolat, Parag
    Evans, Douglas B.
    Tsai, Susan
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (05) : 581 - 586
  • [29] Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer
    Cho, In Rae
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    Seong, Jinsil
    Hwang, Ho Kyoung
    Kang, Chang Moo
    Lee, Woo Jung
    Park, Jeong Youp
    PANCREATOLOGY, 2013, 13 (05) : 539 - 543
  • [30] Predictors of Undergoing Surgical Resection after Neoadjuvant Chemoradiotherapy for Borderline Resectable and Resectable Pancreatic Adenocarcinoma
    Neibart, S. S.
    Mamidanna, S.
    Chundury, A.
    Sayan, M.
    Alexander, H. R.
    August, D.
    Berim, L. D.
    Boland, P. M.
    Grandhi, M. S.
    Gulhati, P.
    Kennedy, T. J.
    Langan, R. C.
    Spencer, K.
    Jabbour, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E63 - E64
12345